Abstract:Alzheimer's disease is the most common neurodegenerative disease in the elderly. The pathogenesis of the disease is still unkown. β-amyloid (Aβ) has been demonstrated to involve the molecular mechanism of the disease. The aim of the present study is to investigate the toxic effect of the carboxyl-terminal peptide of β-amyloid precursor protein (APPC31) on Neuro2a cells as well as its role in the toxic process in Neuro2a cells induced by Aβ 42 in vitro. The plasmid vector and the APPC31 construct were transiently transfected into Neuro2a cells respectively by lipofectamine 2000. The viability of the cells was measured by the methyl thiazolyl tetrazolium (MTT) assay at 48 h after transfection, and their morphocytology was observed by 4,6-diamino-2-phenyl indole (DAPI) nucleus staining. Afterword different constructs including vector, WTAPP695, APP(D664A), the amino-terminal peptide of β-amyloid precursor protein (APPΔC31) and APPC31 were transiently transfected into Neuro2a cells respectively via the same method. At 24 h after transfection Aβ42 was added into the culture medium of Neuro2a cells with the desired concentration for another 24 h for cell studies. The viability and morphocytology of the cells were measured by using the MTT assay and DAPI nucleus staining, respectively. When incubated in the absence of Aβ42, the viability of cells transfected with vector and APPC31 construct were respective 0.81 ± 0.10 and 0.88 ± 0.12, and accordingly there was no significant difference between the these two groups (t = -0.78, P = 0.48); meanwhile no obvious cell nuclear morphological changes of apoptosis or death occurred. However when incubated in the presence of Aβ42, the viability of cells transfected with vector, WTAPP695, APP(D664A), APP–3C31 and APPC31 constructs were respective 0.82 ± 0.01, 0.78 ± 0.03, 0.55 ± 0.04, 0.81 ± 0.04, 0.78 ± 0.02 and 0.54 ± 0.02. The viability of cells transfected with WTAPP construct and APPC31 construct decreased significantly (F = 47.53, P<0.05) compared with the control group, meanwhile cells displayed condensed nuclear and even nuclear fragmentation. The overexpression of a certain level of APPC31 in Neuro2a cells failed to cause cell death, but this short peptide enhanced cytotoxicity induced by Aβ42 in Neuro2a cells. Thus, these results provided the experimental basis for the further explication of the pathogenesis of Alzheimer's disease.

β-Amyloid<sub>42</sub> Induces Desensitization of CXC Chemokine Receptor-4 <i>via</i> Formyl Peptide Receptor in Neural Stem/Progenitor Cells

Beta-Amyloid(42) Induces Desensitization of Cxc Chemokine Receptor-4 Via Formyl Peptide Receptor in Neural Stem/Progenitor Cells

Amyloid-β1-42 Dynamically Regulates the Migration of Neural Stem/progenitor Cells Via MAPK-ERK Pathway.

[Effects of Neural Stem Cells Transplanted into an Animal Model of Alzheimer Disease on Aβ Plaques].

Amyloid-|[beta]|1|[ndash]|42 oligomer accelerates senescence in adult hippocampal neural stem|[sol]|progenitor cells via formylpeptide receptor 2

Stimulation of autophagy prevents amyloid-β peptide-induced neuritic degeneration in PC12 cells.

[Effects of Transplanted Neural Stem Cells on Synaptogenesis in APP/PS1 Mice].

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Amyloid- β 1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2

Effects Of Neural Stem Cells On Synaptic Proteins And Memory In A Mouse Model Of Alzheimer'S Disease

Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an App/Ps1 Double Transgenic Model of Alzheimer'S Disease

N-Stearoyl-L-Tyrosine Inhibits the Senescence of Neural Stem/Progenitor Cells Induced by Aβ1–42via the CB2 Receptor

RhoC Involved in the Migration of Neural Stem/Progenitor Cells

The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

P4‐188: MAPKS SIGNALING PATHWAYS REGULATES THE ACTIVATION OF LRP1 RECEPTOR ON THE INTERNALIZATION OF Aβ <sub>1‐42</sub> AND Aβ <sub>1‐42</sub> ‐INDUCED NEUROTOXICITY

Effects of the Monomeric, Oligomeric, and Fibrillar A Beta(42) Peptides on the Proliferation and Differentiation of Adult Neural Stem Cells from Subventricular Zone

Effect of Regulation of Chemerin/Chemokine-like Receptor 1/Stimulator of Interferon Genes Pathway on Astrocyte Recruitment to Aβ Plaques

Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity.

CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway

Investigation of the Subcellular Neurotoxicity of Amyloid‐β Using a Device Integrating Microfluidic Perfusion and Chemotactic Guidance

β-Amyloid&lt;sub&gt;42&lt;/sub&gt; Induces Desensitization of CXC Chemokine Receptor-4 &lt;i&gt;via&lt;/i&gt; Formyl Peptide Receptor in Neural Stem/Progenitor Cells